Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image21th April 2025 Vol. No. 14 ; Issue No.679
Publications

1. Lester-Coll N, Pra A, Murthy V, Kamran S (2025). Advancements in prostate cancer radiotherapy: The role of PSMA PET imaging, Practical Radiation Oncology.

2. Ghosh S, Wadasadawala T, Mohanty S, Sarin R, Parmar V, Gupta S (2025). Temporal evolution in patient-reported outcomes in Indian women with breast cancer: A longitudinal Study. JCO Global Oncology.

Site of the Week

Translate is a tool which allows the translation of a nucleotide (DNA/RNA) sequence to a protein sequence.

desktop Image
Interesting Reads

Xing X, Zhong J, Biermann J, Duan H, Zhang X, Shi Y, Gao Y, He K, Zhai D, Luo F, Lai Y, Xiao F, Wang W, Wang M, Xu J, Liu H, Tang J, Chu L, Chen T, D'Souza EK, Caprio L, Ebel L, Biswas D, Cottarelli A, Mou Y, Izar B, Zhang N, Bai F (2025). Pan-cancer human brain metastases atlas at single-cell resolution. Cancer Cell.

Video of the Week
First-line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement
Upcoming Events
Immunology in Health & Disease- Coupling Ayurveda with Life Sciences

April 29-30, 2025

At ACTREC, Tata Memorial Centre, Kharghar

Workshop on Clinical Research Methods and Protocol Development- AAZPIRE 2025

May 15-18, 2025

At ACTREC, Tata Memorial Centre, Kharghar , Navi Mumbai

Conference & Hands-On Workshop: From Reconstruction to Restoration

June 21, 2025

At ACTREC, Tata Memorial Centre, Kharghar , Navi Mumbai

Do You Know?

In 1995, Tretinoin ( Vesanoid), a drug related to vitamin A was found to cause remission in patients with acute promyelocytic leukemia (APL).

back Image
Cancer News
Inherited DNA as Well as tumor mutations drive cancer.

Inside Precision Medicine, 15/04/2025

The study revealed the impact of germline variants on individual cancer proteomes using a high throughput process known as precision peptidomics, which involves the quantification of peptides carrying genetic variants...

Reprogramming cancer cells to treat an aggressive type of leukemia

MedicalXpress, 16/04/2025

Using mouse leukemic cells, the researchers screened multiple molecules for such synergies, eventually settling on an inhibitor of the GSK3α/β enzyme. The GSK3 inhibitor is already being evaluated as a cancer drug in clinical trials and is well tolerated by patients...

Study evaluates effect of oxidizing compounds on melanoma cells

Eurekalert, 16/04/2025

The study showed that the sterols ergosterol and 7-DHC provide greater membrane protection than cholesterol in radical oxidation (type I). However, in singlet oxygen-mediated oxidation (type II), cholesterol proved to be more effective...

2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)